Adaptor Protein Lnk Binds to and Inhibits Normal and Leukemic FLT3

被引:0
|
作者
Lin, Dechen [1 ]
Yin, Tong [1 ]
Koren-Michowitz, Maya [1 ]
Ding, Ling-Wen [2 ]
Gueller, Saskia [3 ]
Gery, Sigal [1 ]
Tabayashi, Takayuki [1 ]
Bergholz, Ulla [4 ]
Kazi, Julhash [5 ]
Ronnstrand, Lars [5 ]
Stocking, Carol [4 ]
Koeffler, Phillip [1 ]
机构
[1] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA
[2] Canc Sci Inst Singapore, Singapore, Singapore
[3] Goethe Univ Frankfurt, Dept Med Hematol Oncol, Frankfurt, Germany
[4] Heinrich Pette Inst, Hamburg, Germany
[5] Lund Univ, Skane Univ Hosp, Malmo, Sweden
关键词
D O I
10.1182/blood.V120.21.1312.1312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1312
引用
收藏
页数:2
相关论文
共 50 条
  • [21] The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML cells expressing a constitutively activated FLT3
    Dirschinger, RJ
    Schwab, R
    Faber, F
    Buske, C
    Schnittger, S
    Kelly, LM
    Gilliland, DG
    Hiddemann, W
    Spiekermann, K
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S84
  • [22] Adaptor Protein LNK Binds to and Is Phosphorylated by JAK3 and May Serve as a Scaffold for JAK3 Autophosphorylation In the Absence of An Appropriate Cytokine Receptor
    Koren-Michowitz, Maya
    Gery, Sigal
    Nowak, Daniel
    Nagler, Arnon
    Matsubara, Aiko
    Tabayashi, Takayuki
    Ogawa, Seishi
    Koeffler, H. Phillip
    BLOOD, 2010, 116 (21) : 1147 - 1148
  • [23] Lymphocyte-specific adaptor protein, LNK, inhibits angiotensin II-induced hypertension and inflammation
    Saleh, Mohamed A.
    Harrison, David G.
    Madhur, Meena S.
    FASEB JOURNAL, 2013, 27
  • [24] Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia
    S Horiike
    S Yokota
    M Nakao
    T Iwai
    Y Sasai
    H Kaneko
    M Taniwaki
    K Kashima
    H Fujii
    T Abe
    S Misawa
    Leukemia, 1997, 11 : 1442 - 1446
  • [25] Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia
    Horiike, S
    Yokota, S
    Nakao, M
    Iwai, T
    Sasai, Y
    Kaneko, H
    Taniwaki, M
    Kashima, K
    Fujii, H
    Abe, T
    Misawa, S
    LEUKEMIA, 1997, 11 (09) : 1442 - 1446
  • [26] CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin
    Jetani, Hardikkumar
    Garcia-Cadenas, Irene
    Nerreter, Thomas
    Rydzek, Julian
    Thomas, Simone
    Herr, Wolfgang
    Sierra, Jordi
    Bonig, Halvard
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2017, 130
  • [27] Set Protein Is Involved in FLT3 Membrane Trafficking
    Marcotegui, Nerea
    Romero-Murillo, Silvia
    Marco-Sanz, Javier
    Peris, Irene
    Berrozpe, Blanca S. S.
    Vicente, Carmen
    Odero, Maria D.
    Arriazu, Elena
    CANCERS, 2023, 15 (08)
  • [28] Oncogenic protein tyrosine kinasesNormal and oncogenic FLT3
    T. Naoe
    H. Kiyoi
    Cellular and Molecular Life Sciences CMLS, 2004, 61 (23): : 2932 - 2938
  • [29] Effect of FLT3 inhibition on normal hematopoietic progenitor cells
    Weisel, Katja C.
    Yildirim, Sedat
    Schweikle, Eric
    Kanz, Lothar
    Moehle, Robert
    HEMATOPOIETIC STEM CELLS VI, 2007, 1106 : 190 - 196
  • [30] Selective FLT3 inhibition uncovers the role of FL and FLT3 in normal CD34+hematopoietic stem cells.
    Weisel, Kalja C.
    Yildirim, Sedat
    Xue, Xingkui
    Kanz, Lothar
    Mohle, Robert
    BLOOD, 2006, 108 (11) : 388A - 388A